Nurse Practitioner Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Taylor Dieter

Plastic and Reconstructive Surgery Columbia, SC Nurse Practitioner

NPI 1013430420 CMS profile 4076512

220 Graces Way, Columbia, SC 29229

Open in the dashboard

General payments

$8,577

412 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Taylor Dieter of Columbia, SC is reported in the CMS Open Payments database as having received $8,577 across 412 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 80th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $655 20
2024 General $950 30
2023 General $870 32
2022 General $3,983 203
2021 General $2,070 124
2020 General $33 2
2019 General $17 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Taylor Dieter
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Taylor Dieter were reported at $655. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Taylor Dieter Plastic and Reconstructive Surgery median Middle half National median
2019 $17 $335 $121–$1,264 $163
2020 $33 $162 $57–$417 $114
2021 $2,070 $245 $89–$735 $132
2022 $3,983 $325 $120–$932 $149
2023 $870 $343 $129–$999 $160
2024 $950 $390 $141–$1,085 $164
2025 $655 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $3,016 139 payments
  2. Almirall LLC $1,142 10 payments
  3. Mayne Pharma Inc. $570 73 payments
  4. Amgen Inc. $389 15 payments
  5. Novartis Pharmaceuticals Corporation $341 23 payments
  6. Regeneron Healthcare Solutions, Inc. $341 13 payments
  7. Sun Pharmaceutical Industries Inc. $319 20 payments
  8. Janssen Scientific Affairs, LLC $246 2 payments
  9. Galderma Laboratories, L.P. $245 8 payments
  10. Lilly USA, LLC $223 14 payments
  11. Other $1,746 95 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $7,457 409 payments
  2. Consulting Fee $1,000 1 payment
  3. Education $120 2 payments
Products named General payments · program years 2019–2025
  1. Klisyri $1,022 3 payments
  2. BOTOX $806 34 payments
  3. SKYRIZI $427 41 payments
  4. TREMFYA $380 8 payments
  5. Otezla $367 14 payments
  6. COSENTYX $341 23 payments
  7. DUPIXENT $341 13 payments
  8. HUMIRA $303 25 payments
  9. ILUMYA $255 17 payments
  10. Cimzia $217 10 payments
  11. Other $2,924 162 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

412 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record